The microbiota-gut-brain axis (MGBA) regulates the reciprocal interaction between chronic inﬂammatory bowel and psychiatric disorders. This interaction involves multiple pathways that are highly debated. We examined the behavioral, biochemical and electrophysiological alterations, as well as gut microbiota composition in a model of antibiotic-induced experimental dysbiosis. Inﬂammation of the small intestine was also assessed. Mice were exposed to a mixture of antimicrobials for 2weeks. Afterwards, they received Lactobacillus casei DG (LCDG) or a vehicle for up to 7days via oral gavage. Perturbation of microbiota was accompanied by a general inﬂammatory state and alteration of some endocannabinoidome members in the gut. Behavioral changes, including increased immobility in the tail suspension test and reduced social recognition were observed, and were associated with altered BDNF/TrkB signaling, TRPV1 phosphorylation and neuronal ﬁring in the hippocampus. Moreover, morphological rearrangements of non-neuronal cells in brain areas controlling emotional behavior were detected. Subsequent probiotic administration, compared with vehicle, counteracted most of these gut inﬂammatory, behavioral, biochemical and functional alterations. Interestingly, levels of Lachnospiraceae were found to signiﬁcantly correlate with the behavioral changes observed in dysbiotic mice. Our ﬁndings clarify some of the biomolecular and functional modiﬁcations leading to the development of aﬀective disorders associated with gut microbiota alterations.
Guida F, Turco F, Iannotta M, De Gregorio D, Palumbo I, Sarnelli G, Furiano A, Napolitano F, Boccella S, Luongo L, Mazzitelli M, Usiello A, De Filippis F, Iannotti FA, Piscitelli F, Ercolini D, de Novellis V, Di Marzo V, Cuomo R, Maione S
Part of the information contained in this website is exclusively addressed to healthcare professionals. Please confirm that you are a healthcare professional. Are you a healthcare professional?
This website contains links/references to third-party websites. By such links, SOFAR does not provide any guarantee nor gives its approval to their contents and quality. SOFAR does not have and does not accept any responsibility for the contents or the availability of such websites; SOFAR does not accept any liability for damage or injury resulting from the use of such contents, of whatever form. Users access such websites at their own risk. The information contained in this website is for information purposes only and not for diagnostic or therapeutic purposes. Thus, it does not substitute in any way medical and /or expert or other healthcare professionals or specialists ‘advice.